Nigeria's pharmaceutical research community has achieved another international milestone as two research abstracts submitted by the Community Pharmacists Assessment and Career Progression Institute (CPACPI) were accepted for presentation at the 84th International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences in Montreal, Canada.
The congress, scheduled to take place from August 30 to September 2, 2026, is recognized as the world's largest gathering of pharmacy professionals and stakeholders. It brings together researchers, policymakers, educators, regulators, and healthcare practitioners to advance pharmaceutical innovation and improve healthcare delivery globally.
This recognition is being celebrated as a major boost for Nigeria's growing influence in the international pharmaceutical community and a validation of the country's expanding role in evidence-based pharmacy practice and professional development.
The achievement follows earlier recognition during the previous FIP Congress in Denmark, where the National Chairman of the Association of Community Pharmacists of Nigeria (ACPN), Ambrose Igwekamma Ezeh, introduced the standardized CPACPI framework. The framework was later adopted by the FIP Community Pharmacy Section, a development widely described as a landmark achievement for Nigerian pharmacy practice.
The acceptance of the two abstracts reflects increasing global interest in reforms emerging from Nigeria's community pharmacy sector, particularly in the areas of workforce development, career progression, competency enhancement, and primary healthcare delivery.
Accepted Research Studies
The accepted abstracts were submitted by CPACPI Board Chairman Iyeseun Asieba and ACPN National Secretary Omokhafe Mary Ashore. Both researchers described the recognition as an affirmation of the quality and relevance of Nigerian pharmaceutical research on the global stage. The studies were supervised by the Research and Publications Subcommittee led by Chukwuemeka Ubaka.
One of the accepted studies, titled "The Implementation Gap: Perceived Barriers and External Threats to Community Pharmacists' Participation in a Career Advancement Scheme in Nigeria", will be presented by Asieba. This research examines systemic barriers, institutional limitations, regulatory concerns, and external pressures affecting the participation of Nigerian community pharmacists in structured career progression programs. It also highlights challenges associated with professional growth, competency development, and sustainable workforce advancement within the community pharmacy sector.
Speaking on the development, Asieba described the acceptance as both rewarding and encouraging. According to him, the recognition demonstrates that the experiences, challenges, and innovations emerging from Nigerian pharmacy practice are attracting international attention and possess wider global relevance. He further described the reforms championed by CPACPI under the leadership of Ezeh as transformational initiatives capable of reshaping community pharmacy practice across regions facing similar healthcare delivery and professional development challenges.
The second accepted abstract, titled "Beyond the Counter: Profiling the Early Adopters of a Career Progression Framework among Nigerian Community Pharmacists", will be presented by Ashore. This research explores the motivations, behavioral patterns, professional characteristics, and practice realities of pharmacists who adopted the CPACPI framework during its early implementation phase. It also provides data-driven insights into the evolving structure of community pharmacy practice in Nigeria and the growing importance of standardized career advancement systems.
Reacting to the recognition, Ashore described the development as inspiring and significant, stressing that locally generated healthcare research can influence global healthcare discussions and policy direction.
Global Recognition for Nigerian Pharmacy
Also speaking, Ezeh expressed satisfaction over the increasing global visibility of Nigerian pharmaceutical practice. According to him, strengthening competencies, institutionalizing structured career progression, and improving professional pathways among community pharmacists remain critical to building resilient and patient-centered healthcare systems. He added that the international exposure expected from the upcoming presentations would encourage wider institutional support for the CPACPI model across Nigeria's healthcare ecosystem.
